Qian Yang

While patients with T-lymphoblastic lymphoma (T-LBL) now generally have a favorable prognosis, with 3-year event-free survival rate approaching 69.2%, refractory T-LBL in older adults is almost invariably fatal, exhibiting a dismal 5-year overall survi…

The pathogenesis of autoimmune hemolytic anemia (AIHA) remains incompletely understood, typically associated with immune dysfunction and the production of autoantibodies. Zuberitamab, a novel anti-CD20 monoclonal antibody, represents an important thera…